rTMS for Adolescents and Young Adults
| Status: | Archived |
|---|---|
| Conditions: | Depression, Major Depression Disorder (MDD) |
| Therapuetic Areas: | Psychiatry / Psychology, Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | October 2009 |
| End Date: | October 2011 |
rTMS for Adolescent and Young Adult Depression
rTMS is a promising, though largely untested, option for treating adolescent and young adult
depression. This study hypothesizes that rTMS will safely and significantly alleviate
depression and decrease suicidal ideation in adolescents and young adults based on previous
studies.
After signing consent and undergoing a thorough screening, participants will be administered
rTMS 5 days per week for 4 consecutive weeks (a total of 20 sessions) as an add-on to their
current antidepressant regime. Adolescents must be accompanied by a parent or legal
guardian. We will monitor for depression, anxiety and suicidal ideation over the 4 weeks as
well as 1 week following the last rTMS administration using rating scales. These scales will
be given once a week, on Fridays, and will require roughly 40 minutes to complete. TMS
sessions will last approximately 25 minutes each.
We found this trial at
1
site
Johns Hopkins Hosp From the 1889 opening of The Johns Hopkins Hospital, to the opening...
Click here to add this to my saved trials
